All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
AAHP Reinforces MediNatura’s Defense Against FDA Action
In support of our member company MediNatura, Inc. challenging FDA’s attack on its prescription injectable homeopathic products, AAHP filed an amicus brief in the United...
Key Findings from AAHP’s Homeopathic Shopper Report & Panel
To help homeopathic manufacturers and marketers best serve consumers during this unusual time in history, AAHP surveyed nearly 600 dedicated homeopathy users. The results might...
Sourcing Homeopathic Active Pharmaceutical Ingredients: Controls, Arrangements
By Mark Land, AAHP President In light of recent warning letters to homeopathic manufacturers, I have received several questions regarding procurement of homeopathic active pharmaceutical...
2019-2020 HPUS Changes: What Homeopathic Companies Need to Know
The AAHP hosted a webinar in June on Homeopathic Pharmacopoeia Updates 2019-2020: Essential Information Companies Need to Know. During the course of this concise webinar,...
Legal Memo: Overview of Recent Warning Letters
AAHP Counsel, Al Lorman, has prepared a memo with an overview of recent warning letters, especially highlighting issues raised in the group of warning letters...
Two Additional Topics Expand Continuing Education Program for Pharmacists on Homeopathic Drugs
Topics on colds and flu and calendula were recently launched through Pharmacy Times Continuing Education (PTCE), division of Pharmacy Times®. Pharmacists and pharmacy technicians can...
How to Stop Bad Inspections: It Starts with Staff
By Mark Land, AAHP President At AAHP, we firmly believe that compliance with quality and safety regulations is crucial for all homeopathic manufacturers. To...
